Stockscreener 앱 받기
2.09
0.00%
0.00
시간 외 거래:
1.98
-0.11
-5.26%
전일 마감가:
$2.09
열려 있는:
$2.18
하루 거래량:
40,967
Relative Volume:
66.00
시가총액:
$N/A
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+0.00%
1개월 성능:
+0.00%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$1.91
$2.18
1주일 범위
$1.91
$2.18
52주 변동 폭
$1.91
$2.18
Medicus Pharma Ltd Stock (MDCX) Company Profile
MDCX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| MDCX | 2.09 | 0 | 0 | 0 | 0 | 0.00 |
| VRTX | 467.01 | 119.87B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 762.00 | 83.27B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 567.90 | 33.96B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 232.27 | 30.18B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 101.87 | 24.42B | 3.30B | -501.07M | 1.03B | 11.54 |
Medicus Pharma Ltd 주식(MDCX)의 최신 뉴스
Medicus Pharma unveils ex-GSK and Pfizer senior as chief medical officer - Proactive Investors Australia
Leadership Changes at Medicus Pharma Ltd - TipRanks
Medicus Pharma Strengthens Leadership Team, Advances Skin Cancer Treatment Trial | MDCX Stock News - StockTitan
Medicus Pharma makes debut on Nasdaq raising $4M to advance skin cancer trialICYMI - Proactive Investors Australia
Medicus Pharma Closes $4M IPO, Trades on Nasdaq - TipRanks
MDCXMDCX Latest Stock News & Market Updates - StockTitan
Medicus Pharma completes IPO, becomes second local life sciences company to go public in 2024 - The Business Journals
Medicus Pharma CEO Dr Raza Bokhari on $4M Nasdaq IPO & Phase 2 trial - Proactive Investors USA
Medicus Pharma prices IPO at $4.125 per unit - MSN
Canada Market's biggest losers: Medicus Pharma Ltd. -40.99%, Bragg Gaming Group Inc. -24.43% at midday - Business Upturn
Canada Market's top losers: Pangenomic Health Inc. down 78.67%, Medicus Pharma Ltd down 42.99% - Business Upturn
Medicus Pharma announces pricing of US IPO - Proactive Investors Australia
Medicus Pharma prices IPO at $4.125 per unit (TSXV:MDCX:CA) - Seeking Alpha
Medicus Pharma Announces $4M U.S. IPO Pricing - TipRanks
Exro Technologies Inc (EXRO-T) QuotePress Release - The Globe and Mail
American Express Company (AXP-N) QuotePress Release - The Globe and Mail
Medicus Pharma readies for IPO as it targets $20B industry - The Business Journals
Teledyne Technologies Inc (TDY-N) QuotePress Release - The Globe and Mail
Medicus Pharma consolidates shares ahead of expected US stock exchange listing - Proactive Investors Australia
Medicus Pharma Ltd. Announces Share Consolidation in Anticipation of Proposed U.S. Listing - Newsfile
V.MDCX: Medicus Pharma Randomizes First Patient in SKNJCT-003 Phase 2 clinical trial for the treatment of nodular BCC (Basal Cell Carcinoma). - Yahoo Finance
Is Philadelphia a hub for Biotech? 215 Capital is betting on it, says Ajay Raju Biotechnology - The American Bazaar
215 Capital invests $8 million in Medicus Pharma Ltd. - The American Bazaar
Medicus Pharma Ltd. Announces Closing of Non-Brokered Private Placement of Common Shares and Conversion of Convertible Notes - Yahoo Finance
FSD Pharma, Inc. Wins Final Judgment to Confirm Arbitration Award of $3,059,998 Plus Interest Entered Against Dr. Raza Bokhari, Currently Serving as Chairman and CEO of Medicus Pharma Ltd. - Yahoo Finance
Medicus Pharma files plan for U.S. IPO - The Business Journals
Medicus Pharma Ltd. Announces Filing of Registration Statement for Proposed Initial Public Offering in the United States - Newsfile
Medicus Pharma Opens the Market - Canada NewsWire
Medicus Pharma Ltd. Announces Closing of Business Combination - Newsfile
Medicus Pharma Ltd (MDCX) 재무 분석
Medicus Pharma Ltd (MDCX)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
3.66%
1.11%
자본화:
|
볼륨(24시간):